Pharma

The agency urged doctors to stop prescribing the drugs outside of their licenses to ease shortages.

Vital drugs are either not authorized or are deemed too expensive, as cases rise.

A German policy requiring pharmaceutical companies to hold six months worth of certain types of stock will squeeze other countries, says Czech deputy health minister.

Belgian Health Minister Frank Vandenbroucke has a great CV for the EU’s top health post. But will Belgium let him go?

Green members debunk historical and recent dubious positions on public health policies.

Lawmakers brace for less support for public health and Big Pharma, but the generics sector looks set to win.

Countries have become entrenched in their positions on intellectual property and sharing vaccines and drugs.

With just a week to go until the European election and the campaign in full gear, we’re focusing on how the vote will impact key EU policies …

Negotiators for developing countries refused to sign up to a deal that failed to guarantee their countries access to life-saving drugs and vaccines.

A study found that treatment with Wegovy has long-term cardiovascular benefits and sustainable weight loss for patients.

There is no evidence to suggest a link between the use of weight loss drugs like Ozempic and suicidal thoughts, the EU’s drugs regulator has found. The …

Internal government documents reveal scale of vaccine excess from vast EU contracts.

Margrethe Vestager and Frans Timmermans among officials tested as EU debates potential ban.

Negotiators on a treaty to guide the world’s response to the next pandemic oppose any requirement to share drugmakers’ intellectual property.

With less than six months to go, countries are still not really negotiating, say diplomats.

A Christmas gift for all the policy wonks out there.

While the European Commission wants to standardize hospital-made cell and gene therapies, the Parliament’s draft report would curtail them.

The romantic relationship between Pernille Weiss and Christian Ehler has raised questions about why an independent study was taken offline.

A European Parliament study that centers on the delicate topic of incentives for drug companies was published, then pulled offline again, pending further queries from MEPs.